Trial Outcomes & Findings for Effect of Fenugreek on Milk Production (NCT NCT00851591)
NCT ID: NCT00851591
Last Updated: 2018-06-26
Results Overview
The single value of this variable was calculated average from day 0 and day 8.
TERMINATED
NA
3 participants
"Day 0" , "Day 8"
2018-06-26
Participant Flow
3 patients were recruited to participate. Recruitment was stopped due to a similar study had already been published and the inability to recruit patients.
Participant milestones
| Measure |
1 Group Scheduled to Receive Fenugreek
fenugreek: 3 capsules 3 times per day with a full glass of water each dose for 7 days
|
2 Group Scheduled to Receive Placebo
Psyllium: 3 capsules 3 times a day with a full glass of water each dose for 7 days
|
|---|---|---|
|
Overall Study
STARTED
|
2
|
1
|
|
Overall Study
COMPLETED
|
0
|
1
|
|
Overall Study
NOT COMPLETED
|
2
|
0
|
Reasons for withdrawal
| Measure |
1 Group Scheduled to Receive Fenugreek
fenugreek: 3 capsules 3 times per day with a full glass of water each dose for 7 days
|
2 Group Scheduled to Receive Placebo
Psyllium: 3 capsules 3 times a day with a full glass of water each dose for 7 days
|
|---|---|---|
|
Overall Study
Withdrawal by Subject
|
2
|
0
|
Baseline Characteristics
Effect of Fenugreek on Milk Production
Baseline characteristics by cohort
| Measure |
2 Group Scheduled to Receive Placebo
n=1 Participants
Psyllium: 3 capsules 3 times a day with a full glass of water each dose for 7 days
|
1 Group Scheduled to Receive Fenugreek
n=2 Participants
fenugreek: 3 capsules 3 times per day with a full glass of water each dose for 7 days
|
Total
n=3 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
1 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
1 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: "Day 0" , "Day 8"The single value of this variable was calculated average from day 0 and day 8.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: day 0; day 8Population: 0 patient samples
Milk-fat content was not measured in these samples as we had decided to close the study. Protein content was not measured in these samples as we had decided to close the study.
Outcome measures
Outcome data not reported
Adverse Events
1 Group Scheduled to Receive Fenugreek
2 Group Scheduled to Receive Placebo
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Thomas Hale, PhD.
Texas Tech University Health Sciences Center
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place